Cargando…

Adeno‐associated virus (AAV)-based gene therapy for glioblastoma

Glioblastoma (GBM) is the most common and malignant Grade IV primary craniocerebral tumor caused by glial cell carcinogenesis with an extremely poor median survival of 12–18 months. The current standard treatments for GBM, including surgical resection followed by chemotherapy and radiotherapy, fail...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Xin, Chen, Wenli, Zhu, Wenjun, Chen, Jing, Ma, Bin, Ding, Jianxia, Wang, Zaichuan, Li, Yifei, Wang, Yeming, Zhang, Xiaochun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836184/ https://www.ncbi.nlm.nih.gov/pubmed/33499886 http://dx.doi.org/10.1186/s12935-021-01776-4

Ejemplares similares

Gene therapy of adeno‐associated virus (AAV) vectors in preclinical models of ischemic stroke
por: Wang, Jing, et al.
Publicado: (2023)

Adeno-Associated Virus (AAV) as a Vector for Gene Therapy
por: Naso, Michael F., et al.
Publicado: (2017)

Adeno-Associated Virus (AAV) Versus Immune Response
por: Rabinowitz, Joseph, et al.
Publicado: (2019)

Human Immune Responses to Adeno-Associated Virus (AAV) Vectors
por: Ronzitti, Giuseppe, et al.
Publicado: (2020)

Adeno-associated Virus (AAV) Serotypes Have Distinctive Interactions with Domains of the Cellular AAV Receptor
por: Pillay, Sirika, et al.
Publicado: (2017)

Improved adeno-associated virus (AAV) serotype 1 and 5 vectors for gene therapy
por: Sen, Dwaipayan, et al.
Publicado: (2013)

Rapid characterization of adeno-associated virus (AAV) gene therapy vectors by mass photometry
por: Wu, Di, et al.
Publicado: (2022)

Adeno-Associated Virus (AAV) - Based Gene Therapies for Retinal Diseases: Where are We?
por: Ail, Divya, et al.
Publicado: (2023)

Methylation Status of the Adeno-Associated Virus Type 2 (AAV2)
por: Tóth, Renáta, et al.
Publicado: (2019)

Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer
por: Arjomandnejad, Motahareh, et al.
Publicado: (2023)

Adeno-Associated Virus Receptor-Binding: Flexible Domains and Alternative Conformations through Cryo-Electron Tomography of Adeno-Associated Virus 2 (AAV2) and AAV5 Complexes
por: Hu, Guiqing, et al.
Publicado: (2022)

 Adeno-associated Virus (AAV) Dual Vector Strategies for Gene Therapy Encoding Large Transgenes
por: McClements, Michelle E., et al.
Publicado: (2017)

Characterization of Recombinant Adeno-Associated Viruses (rAAVs) for Gene Therapy Using Orthogonal Techniques
por: Cole, Liam, et al.
Publicado: (2021)

Modular adeno-associated virus (rAAV) vectors used for cellular virus-directed enzyme prodrug therapy
por: Hagen, Sven, et al.
Publicado: (2014)

Pre-Clinical Assessment of Immune Responses to Adeno-Associated Virus (AAV) Vectors
por: Basner-Tschakarjan, Etiena, et al.
Publicado: (2014)

Creating an arsenal of Adeno-associated virus (AAV) gene delivery stealth vehicles
por: Smith, J. Kennon, et al.
Publicado: (2018)

Molecular design for recombinant adeno-associated virus (rAAV) vector production
por: Aponte-Ubillus, Juan Jose, et al.
Publicado: (2017)

Proteomic Landscape of Adeno-Associated Virus (AAV)-Producing HEK293 Cells
por: Strasser, Lisa, et al.
Publicado: (2021)

A Generic Method for Fast and Sensitive Detection of Adeno-Associated Viruses Using Modified AAV Receptor Recombinant Proteins
por: Cui, Mengtian, et al.
Publicado: (2019)

Adeno-Associated Virus (AAV)-Mediated Gene Therapy for Duchenne Muscular Dystrophy: The Issue of Transgene Persistence
por: Manini, Arianna, et al.
Publicado: (2022)

CXCL9 recombinant adeno-associated virus (AAV) virotherapy sensitizes glioblastoma (GBM) to anti-PD-1 immune checkpoint blockade
por: von Roemeling, Christina, et al.
Publicado: (2023)

Hydroxylation of N-acetylneuraminic Acid Influences the in vivo Tropism of N-linked Sialic Acid-Binding Adeno-Associated Viruses AAV1, AAV5, and AAV6
por: Lopez-Gordo, Estrella, et al.
Publicado: (2021)

Optimization of the Capsid of Recombinant Adeno-Associated Virus 2 (AAV2) Vectors: The Final Threshold?
por: Aslanidi, George V., et al.
Publicado: (2013)

Adeno-Associated Viruses (AAV) and Host Immunity – A Race Between the Hare and the Hedgehog
por: Rapti, Kleopatra, et al.
Publicado: (2021)

Hepatocellular Carcinoma Is a Natural Target for Adeno-Associated Virus (AAV) 2 Vectors
por: Meumann, Nadja, et al.
Publicado: (2022)

Therapeutic Applications of Adeno-Associated Virus (AAV) Gene Transfer of HLA-G in the Eye
por: Gilger, Brian C., et al.
Publicado: (2022)

The X Gene of Adeno-Associated Virus 2 (AAV2) Is Involved in Viral DNA Replication
por: Cao, Maohua, et al.
Publicado: (2014)

Adeno-Associated Virus (AAV-DJ)—Cryo-EM Structure at 1.56 Å Resolution
por: Xie, Qing, et al.
Publicado: (2020)

Adeno-Associated Virus (AAV) Gene Delivery: Dissecting Molecular Interactions upon Cell Entry
por: Large, Edward E., et al.
Publicado: (2021)

Towards Clinical Implementation of Adeno-Associated Virus (AAV) Vectors for Cancer Gene Therapy: Current Status and Future Perspectives
por: Hacker, Ulrich T., et al.
Publicado: (2020)

Integration of adeno-associated virus (AAV) into the genomes of most Thai and Mongolian liver cancer patients does not induce oncogenesis
por: Schäffer, Alejandro A., et al.
Publicado: (2021)

Hairpin end conformation of adeno-associated virus (AAV) genome determines interactions with DNA repair pathways
por: Cataldi, Marcela P., et al.
Publicado: (2012)

Gene Transfer in Rodent Nervous Tissue Following Hindlimb Intramuscular Delivery of Recombinant Adeno-Associated Virus Serotypes AAV2/6, AAV2/8, and AAV2/9
por: Jan, Asad, et al.
Publicado: (2019)

Serotype-dependent recombinant adeno-associated vector (AAV) infection of Epstein–Barr virus-positive B-cells, towards recombinant AAV-based therapy of focal EBV + lymphoproliferative disorders
por: Ahmadi, Elham, et al.
Publicado: (2021)

Biodistribution of adeno-associated virus serotype 9 (AAV9) vector after intrathecal and intravenous delivery in mouse
por: Schuster, Daniel J., et al.
Publicado: (2014)

Adeno-Associated Virus (AAV) Capsid Stability and Liposome Remodeling During Endo/Lysosomal pH Trafficking
por: Lins-Austin, Bridget, et al.
Publicado: (2020)

Post‐translational modifications in capsid proteins of recombinant adeno‐associated virus (AAV) 1‐rh10 serotypes
por: Mary, Bertin, et al.
Publicado: (2019)

Optimization of adeno-associated virus (AAV) gene delivery into human bone marrow stem cells (hBMSCs)
por: Yao, Shaomian, et al.
Publicado: (2023)

Mutants at the 2-Fold Interface of Adeno-associated Virus Type 2 (AAV2) Structural Proteins Suggest a Role in Viral Transcription for AAV Capsids
por: Aydemir, Fikret, et al.
Publicado: (2016)

Adeno-associated Virus (AAV) Capsid Chimeras with Enhanced Infectivity Reveal a Core Element in the AAV Genome Critical for both Cell Transduction and Capsid Assembly
por: Viney, Lydia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e8t2j3gh8e9jk287p8p4gjd99s